Spiriva Uses
Links shared publicly online about this topic
Spiriva - Uses, Side Effects, Interactions - Drugs - Medbroadcast
medbroadcast.com — “This medication is used once daily for the long-term relief of symptoms such as shortness of breath and wheezing associated with the lung disease known as chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema.” View full resource at medbroadcast.com
Most Recently Shared on January 16, 2010 at 10:31 pm By:
Spiriva - Uses, Side Effects, Interactions … http://short.to/13rzv
Spiriva - Spiriva is an alternative for adult asthmatics, researchers say - Los Angeles Times
articles.latimes.com — “Spiriva, a drug that is already widely used to treat chronic obstructive pulmonary disease, can provide significant relief of symptoms for adult asthmatics who have difficulty obtaining relief with” View full resource at articles.latimes.com
Most Recently Shared on September 19, 2010 at 2:24 pm By:
Spiriva is an alternative for adult asthmatics, researchers say http://lat.ms/auVjEe
Comments of using Spiriva (study 4103516) - eHealthMe.com
ehealthme.com — “For several years Doctors and I have tried to isolate the cause for the hyper photo-sensitivity that I have experienced now for 5 years. The most likely culprit seems to be the Spiriva, an excellent drug for COPD, but it disallows me being in the sun more than a few minutes in the day without a severe burning sensation.” View full resource at ehealthme.com
Most Recently Shared on February 9, 2012 at 3:09 am By:
For several years Doctors and I have tried to isolate the cause for the hyper photo-sensitivity that I have ex http://t.co/fwbTwMSU
The Associated Press: Spiriva as good as Serevent in asthma study
google.com — “The Associated Press: Spiriva as good as Serevent in asthma study” View full resource at google.com
Most Recently Shared on September 19, 2010 at 7:05 pm By:
Dr. Lewis Smith was mentioned in @associated press regarding Spiriva, a drug that is used to relive asthma symptoms http://bit.ly/amsCvE
FDA Updates Earlier Guidance on Respiratory Treatment Spiriva HandiHaler
fda.gov — “The u.s. food and drug administration today announced that data from a recent review of the spiriva handihaler, a long-acting respiratory treatment for chronic obstructive pulmonary disease (copd), do not support an increased risk of stroke, heart attack, or death in patients using the medicine.” View full resource at fda.gov
Most Recently Shared on January 14, 2010 at 8:04 pm By:
FDA Updates Earlier Guidance on Respiratory Treatment Spiriva HandiHaler http://bit.ly/8RuxQm
Spiriva is an alternative for adult asthmatics, study finds - latimes.com
latimes.com — “Though some doctors have already been prescribing the drug — meant to treat chronic obstructive pulmonary disease — for asthma, a new study confirms the benefit of such use.” View full resource at latimes.com
Most Recently Shared on September 20, 2010 at 5:05 pm By:
Spiriva is an alternative for adult asthmatics, study finds - latimes.com http://lat.ms/cAoc1q
Pfizer's Spiriva enhances asthma treatment
health.yahoo.net — “Adding Spiriva to conventional therapy improves symptoms in patients whose asthma is poorly controlled and gives them more days without breathing problems, researchers reported on Sunday.” View full resource at health.yahoo.net
Most Recently Shared on September 19, 2010 at 7:40 pm By:
Pfizer's Spiriva enhances asthma treatment http://bit.ly/bjbbUa
FDA Approves Spiriva HandiHaler for the Reduction of COPD Exacerbations
drugs.com — “Spiriva HandiHaler (tiotropium bromide) is used for the reduction of exacerbations in patients with chronic obstructive pulmonary disease (COPD). Includes Spiriva HandiHaler side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on December 20, 2009 at 7:35 pm By:
FDA Approves Spiriva HandiHaler for the Reduction of COPD Exacerbations - http://bit.ly/8NzjMW
FDA Updates Earlier Guidance On Respiratory Treatment Spiriva HandiHaler
medicalnewstoday.com — “The u.s. food and drug administration announced that data from a recent review of the spiriva handihaler, a long-acting respiratory treatment for chronic obstructive pulmonary disease (copd), do n” View full resource at medicalnewstoday.com
Most Recently Shared on January 15, 2010 at 2:08 pm By:
FDA Updates Earlier Guidance On Respiratory Treatment Spiriva HandiHaler http://mnt.to/3wmD
For Lung Disorder, Spiriva Beat Serevent in Head-to-Head Trial
health.yahoo.net — “WEDNESDAY, March 23 (HealthDay News) -- People with moderate-to-severe chronic obstructive pulmonary disease (COPD) use inhaled long-acting bronchodilators to control symptoms and reduce flare-ups, but which type of drug is best hasn't been clear.” View full resource at health.yahoo.net
Most Recently Shared on March 25, 2011 at 4:40 pm By:
For Lung Disorder, Spiriva Beat Serevent in Head-to-Head Trial http://bit.ly/hPZOrw
Spiriva mist inhaler safety concerns raised | InPharm
inpharm.com — “A mist inhaler used to deliver Spiriva to patients with COPD may be linked to an increased risk of death” View full resource at inpharm.com
Most Recently Shared on June 16, 2011 at 9:43 am By:
Spiriva mist inhaler safety concerns raised http://goo.gl/fb/783qN
FDA finds no heart risk with Spiriva inhaler - More health news- msnbc.com
msnbc.msn.com — “Federal health regulators say recent data do not show a connection between a popular respiratory inhaler and previously reported risks of stroke, heart attack and death.” View full resource at msnbc.msn.com
Most Recently Shared on January 14, 2010 at 9:45 pm By:
FDA finds no heart risk with Spiriva inhaler http://bit.ly/4Cdqb5
For Lung Disorder, Spiriva Beat Serevent in Head-to-Head Trial - Drugs.com MedNews
drugs.com — “People with moderate-to-severe chronic obstructive pulmonary disease (COPD) use inhaled long-acting bronchodilators to control symptoms and reduce flare-ups, bu” View full resource at drugs.com
Most Recently Shared on March 24, 2011 at 4:57 am By:
For Lung Disorder, Spiriva Beat Serevent in Head-to-Head Trial - http://bit.ly/hSDy2R
FDA: Data from Spiriva HandiHaler do not support increased risks for stroke, heart attack or death
news-medical.net — “The U.S. Food and Drug Administration today announced that data from a recent review of the Spiriva HandiHaler, a long-acting respiratory treatment for chronic obstructive pulmonary disease (COPD), do not support an increased risk of stroke, heart attack, or death in patients using the medicine.” View full resource at news-medical.net
Most Recently Shared on January 18, 2010 at 9:39 am By:
Stroke News: FDA: Data from Spiriva HandiHaler do not support increased risks for stroke, heart attack or death:... http://twurl.nl/u7qvhw
Spiriva satisfaction and usage data | Monitoring more than 7,600 patients | Drug safety information | MediGuard
mediguard.org — “Spiriva satisfaction and usage data | Monitoring more than 7,600 patients | Drug safety information | MediGuard” View full resource at mediguard.org
Most Recently Shared on April 15, 2011 at 1:17 pm By:
23% of #spiriva users getting side-effects ... http://tinyurl.com/4jp8k9n
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Bo
Internet Entrepreneur interested in health issues, co-founder of DrEveryone.com
-
LA Times Science
Current Science and Medical News from the Los Angeles Times + latimes.com. See latimes.com/twitter for more news streams.
-
eHealthMe.com
eHealthMe provides health professionals and patients personalized tools to study millions of drug reports from FDA and community in real time.
Advertisement

